Posted: January 2, 2007
Pharmaceutical spending on Direct-to-Consumer (DTC) advertising is at an all-time high, with the 2006 budget surpassing the 2005 budget by over 9%, according to TNS and reported in Brandweek .
Before you get all excited, however, realize that practically all and maybe more of that gain of $400 million is due to just two drugs. [Read on to find out which two.]
With this amount of spending on DTC, pharmaceutical marketers have to ask themselves how much is being wasted and how they can improve DTC efficacy and return on investment, which is generally considered to be declining. "DTC in the New Era" includes a review of several techniques for optimizing DTC and improving its outcomes. These ideas are gathered from experts in the field.
For more on this, plus a poll on what you think are the most common DTC mistakes, please see today's post to Pharma Marketing Blog.
For more posts in related topic areas, see:
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
| Return to Pharma Marketing Blog Topics |